![](https://investorshub.advfn.com/uicon/32556.png?cb=1490101632)
Friday, December 08, 2006 12:54:03 PM
7 major classes of branded recombinant protein products accounted for total sales of US$ 32 bln in 2005:
1. Erythropoietins: US$ 11.162 bln
2. Insulins: US$ 7.211 bln
3. Interferons: US$ 5.958 bln
4. G-CSF: US$ 3.968 bln
5. HGH: US$ 2.309 bln
6. FSH: US$ 970mm
7. Thrombolytics: US$ 300mm
Human alpha interferons (a-IFN) are a family of naturally occurring signalling proteins. At least 23 of these predominantly non-glycosylated recombinant a interferons (r-a-IFN) comprising of 165 amino acids and weighing between 19,000 and 20,000 Daltons are recognized. They are used therapeutically for their properties of inducing anti-viral effect, immunomodulation and inhibition of cellular proliferation.
http://www.pipelinereview.com/joomla/content/view/185/83/
http://www.emea.eu.int/pdfs/human/biosimilar/724106en.pdf
On the HepC-only side, Pegasys & Peg-Intron represents upwards of $2.5bb:
Product Effects/therapeutic-use WorldwideSales/2005
Pegasys, anti-HepC: $1.374bb (Roche)
Peg-Intron, anti-HepC: $1.369bb (Schering-Plough)
Total: ~$2.7bb (2005)
http://www.i-s-b.org/business/rec_sales.htm
There are two brands of pegylated interferon: Pegasys and PEG-Intron. There are slight differences between the drugs, but both brands seem to work equally well and do not have major differences in side effects. Both are used in combination with ribavirin to treat HepC virus (HCV) infection.
PEGASYS (Peginterferon alfa-2a) is a medicine used to treat some adults who have HepC or HepB and signs of liver damage. PEGASYS works to reduce the amount of virus in your blood, helping your body fight the virus. Like other alpha interferons, Pegasys can cause fatal or make life-threatening problems worse (like mental, immune system, heart, liver, lung, intestinal and infections). Your doctor should monitor you during regular visits. If you show signs or symptoms of these conditions, your doctor may stop your medication.
PEG-INTRON is a pegylated interferon, a man-made form of interferon, a chemical naturally produced in the body to fight viruses. Interferon helps to stop the HepC virus (HCV) from making new copies of itself. It also helps the immune system to kill HCV. Alpha interferons, including PEG-Intron, may cause or aggravate fatal or life-threatening neuropsychi-atric, autoimmune, ischemic, and infectious disorders. Patients should be monitored closely with peri-odic clinical and laboratory evaluations. Patients with persistently severe or worsening signs or symp-toms of these conditions should be withdrawn from therapy. In many but not all cases these disorders resolve after stopping PEG-Intron therapy.
Recent CDMO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 08:30:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 12:23:26 AM
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM